102 results on '"A von dem Borne P"'
Search Results
2. Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT
3. Adenovirus infections after allogeneic hematopoietic cell transplantation in children and adults: a study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
4. Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)
5. Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
6. Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
7. Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients
8. Effect of invasive aspergillosis on risk for different causes of death in older patients with acute myeloid leukaemia or high-risk myelodysplastic syndrome
9. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT
10. Haploidentical transplantation in patients with multiple myeloma making use of natural killer cell alloreactive donors
11. Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study
12. Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status
13. Donor T-cell responses and disease progression patterns of multiple myeloma
14. A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short- but not on long-term survival of patients with AML or high-risk MDS
15. Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT
16. Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
17. Physiochemical disparity of mismatched HLA class I alloantigens and risk of acute GVHD following HSCT
18. Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL
19. Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT
20. Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation
21. Oral bacteria and yeasts in relationship to oral ulcerations in hematopoietic stem cell transplant recipients
22. Viral loads and antiviral resistance of herpesviruses and oral ulcerations in hematopoietic stem cell transplant recipients
23. Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT
24. Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia
25. MULTI-STATE MODELS ENHANCE INSIGHT IN OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR AML/MDS FOLLOWED BY DONOR LYMPHOCYTE INFUSIONS: PH-P399
26. Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells
27. Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with < 10% BM blasts: a report from EBMT
28. The impact of frequent HLA haplotypes in high linkage disequilibrium on donor search and clinical outcome after unrelated haematopoietic SCT
29. Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study
30. Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy
31. E-selectin and very late activation antigen-4 mediate adhesion of hematopoietic progenitor cells to bone marrow endothelium
32. Serum levels of thrombopoietin, IL-11, and IL-6 in pediatric thrombocytopenias
33. Increasing the dose of rabbit-ATG does not lead to a higher response rate in the first-line treatment of severe aplastic anaemia: P1176
34. Feasibility of very low dose donor lymphocyte infusion early after T-cell depleted allogeneic stem cell transplantation: P1038
35. Proper adhesion molecule expression on non-haematopoietic tissues is a requirement for GvHD reactivity by alloreactive effector T-cells: P842
36. Outcome of allogeneic HSCT for patients transformed from aplastic anaemia to MDS or leukaemia. A report by the MDS subcommittee of the Chronic Leukaemia Working Party and the Aplastic Anaemia Working Party of the EBMT: O425
37. Differential susceptibility of B-cells and protective CD8 and CD4 T-cells leads to low incidence of post-transplant EBV-related disease after alemtuzumab-based T-cell depletion: O420
38. Complex karyotype predicts relapse better than monosomal karyotype in patients with MDS/secondary acute leukaemia after allogeneic haematopoietic stem cell transplantation: a survey on behalf of the Chronic Leukaemia Working Party of the EBMT: O413
39. Binding of amyloid β precursor protein to coagulation factor XIa in vivo may favour haemorrhagic stroke
40. Allogeneic stem cell transplantation for multiple myeloma with a T-cell depleted reduced-intensity conditioning regimen using both unrelated and related donors: O160
41. HOVON-50 Final Analysis of Thalidomide Combined with Adriamycin, Dexamethasone, and HDM: A046
42. G-CSF-induced decrease of the anti-granulocyte autoantibody levels in a patient with autoimmune granulocytopenia
43. Pneumocystis carinii Pneumonia in HIV-negative patients with haematologic disease
44. Comparable engraftment and chimerism kinetics using oral and intravenous fludarabine as part of a reduced intensity conditioning regimen
45. The balance between graft-versus-leukemia reactivity and graft-versus-host disease is determined both by minor histocompatibity antigen expression and the presence of inflammatory cytokines in target tissues
46. 99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin’s lymphoma
47. Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCγ -receptor-II-mediated mechanism and by drugs
48. Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)
49. Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women. Evidence for placenta being the primary target for anti-Tja-antibodies
50. Acute inhibitory effect of alcohol on fibrinolysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.